Subscribe: MedWorm: Astigmatism
http://www.medworm.com/rss/medicalfeeds/conditions/Astigmatism.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
astigmatism  cataract  fda  intraocular lens  intraocular  lens  medical  patients  source  staar surgical  toric  total  vision 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Astigmatism

MedWorm: Astigmatism News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Astigmatism



Last Build Date: Wed, 31 Jan 2018 04:29:12 +0100

 



Challenges of Treating Irregular Astigmatism: Ophthalmology Times

Wed, 31 Jan 2018 02:35:02 +0100

(MedPage Today) -- Also, how to handle change (Source: MedPage Today Public Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Johnson and Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISM

Mon, 22 Jan 2018 16:01:00 +0100

Nearly half of vision-corrected patients has astigmatism in at least one eye,(1) and full correction can provide improved visual quality of life(2) JACKSONVILLE, Fla., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision ... Devices, Ophthalmology, Product Launch Johnson & Johnson, Johnson & Johnson Vision, ACUVUE MOIST (Source: HSMN NewsFeed)



RxSight wins FDA nod for light-adjustable IOL

Wed, 22 Nov 2017 19:46:22 +0100

The FDA has cleared RxSight‘s implantable light adjustable intraocular lens and light delivery device. The company’s RxSight IOL is designed from a UV light reactive material meant to be treated by a specific Light Delivery Device, intended for use 17 to 21 days post-procedure. The lens is designed to be treated by 3-4 light treatments over 1 to 2 weeks in 40 to 150 second treatment periods, during which the patient must wear UV-protective glasses. “Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery. This system provides a new option for certain patients that allows the physician to make small adjustments to the implanted lens during several in-office procedures after the initi...



Measuring mental workload: ocular astigmatism aberration as a novel objective index - Jim énez R, Cardenas D, Anera RG, Jiménez JR, Vera J.

Mon, 23 Oct 2017 14:21:03 +0100

This study assessed the effect of two perceptually matched mental tasks with different levels of mental demand on ocular aberrations in a group of young adults. We measured ocular aberration with a wave-front sensor, and total, internal, and corneal RMS (r... (Source: SafetyLit)



Minimizing Astigmatism in Cataract Surgery Minimizing Astigmatism in Cataract Surgery

Thu, 19 Oct 2017 15:26:52 +0100

Is intraoperative aberrometry or intraoperative markerless guidance more effective in helping to achieve low amounts of astigmatism after cataract surgery? Dr Garg reviews a recent study.Medscape Ophthalmology (Source: Medscape Today Headlines)



Can You Go Blind from Astigmatism?

Mon, 16 Oct 2017 07:00:00 +0100

Title: Can You Go Blind from Astigmatism?Category: Doctor's& Expert's views on SymptomsCreated: 10/16/2017 12:00:00 AMLast Editorial Review: 10/16/2017 12:00:00 AM (Source: MedicineNet Eyesight General)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Can Astigmatism Go Away on Its Own?

Tue, 10 Oct 2017 07:00:00 +0100

Title: Can Astigmatism Go Away on Its Own?Category: Doctor's& Expert's views on SymptomsCreated: 10/10/2017 12:00:00 AMLast Editorial Review: 10/10/2017 12:00:00 AM (Source: MedicineNet Eyesight General)



Is Astigmatism Hereditary?

Mon, 09 Oct 2017 07:00:00 +0100

Title: Is Astigmatism Hereditary?Category: Doctor's& Expert's views on SymptomsCreated: 10/9/2017 12:00:00 AMLast Editorial Review: 10/9/2017 12:00:00 AM (Source: MedicineNet Eyesight General)



7 medtech stories we missed this week: Sept. 15, 2017

Fri, 15 Sep 2017 17:22:11 +0100

[Image from unsplash.com]From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for wound indications. 2. Pinnacle Sciences launches mask-mounted CPAP machine Pinnacle Sciences has recently developed a portable, battery-operated ventilating CPAP mask for sl...



KC eye doc: New LASIK procedure could grow patient base

Tue, 15 Aug 2017 20:05:55 +0100

Dr. John Doane said a growing number of patients are coming to his office for a new surgical alternative to LASIK. Recently approved by the Food and Drug Administration (FDA) to treat nearsighted patients, small incision lenticule extraction (SMILE) makes a tiny incision in the outer cornea, for a shorter recovery time and fewer dry-eye side effects. Doane participated in a clinical trial starting in 2013 and expects it will be approved to treat astigmatism in mid-2018. An opthalmologist at Discover… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)



Bausch and Lomb ULTRA(R) for Astigmatism Contact Lenses Introduced

Thu, 30 Mar 2017 16:31:38 +0100

Innovative Toric Lens Delivers All-Day Comfort and Consistently Clear Vision1 LAVAL, Quebec, March 30, 2017 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bau... Devices, Ophthalmology, Product Launch Bausch & Lomb, ULTRA for Astigmatism, Astigmatism, contact lens (Source: HSMN NewsFeed)



Bausch and Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses

Wed, 15 Mar 2017 15:27:51 +0100

New Innovative Daily Disposable Contact Lens Designed to Provide Astigmatic Patients Consistently Clear Vision and Comfort Throughout the Day LAVAL, Quebec, March 15, 2017 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals Interna... Devices, Ophthalmology, Product Launch Bausch & Lomb, Valeant Pharmaceuticals, Biotrue, Astigmatism, contact lens (Source: HSMN NewsFeed)



FDA Clears New Corrective Intraocular Lens From Alcon FDA Clears New Corrective Intraocular Lens From Alcon

Fri, 03 Feb 2017 21:22:30 +0100

The AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL corrects presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults.FDA Approvals (Source: Medscape Ophthalmology Headlines)



MassDevice.com +5 | The top 5 medtech stories for December 27, 2016

Tue, 27 Dec 2016 20:00:32 +0100

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA approves Alcon’s AcrySof IQ ReStor intraocular lens Novartis‘ eye care business, Alcon, said today that it won FDA approval for its AcrySof IQ ReStor multifocal toric intraocular lens. The lens treats presbyopia and pre-existing corneal astigmatism in adult patients undergoing cataract surgery. The AcrySof IQ ReStor intraocular lens is already commercially available in the E.U., Austral...



FDA approves Alcon ’ s AcrySof IQ ReStor intraocular lens

Fri, 23 Dec 2016 13:46:41 +0100

Novartis‘ (NYSE:NVS) eye care business, Alcon, said today that it won FDA approval for its AcrySof IQ ReStor multifocal toric intraocular lens. The lens treats presbyopia and pre-existing corneal astigmatism in adult patients undergoing cataract surgery. The AcrySof IQ ReStor intraocular lens is already commercially available in the E.U., Australia, Canada, parts of Central and South America and Asia. “The AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL is an important addition to our market-leading IOL portfolio, and broadens our offering of presbyopia- and astigmatism-correcting lenses to meet the different visual needs of patients,” Alcon’s region president for North America Sergio Duplan said in prepared remarks. “We are committed to delivering ongoing inno...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Lensar files for Chapter 11 bankruptcy

Mon, 19 Dec 2016 22:05:19 +0100

Lensar Inc. today filed for Chapter 11 bankruptcy protection, saying it needs to reduce its debt and strengthen its balance sheet and platform for future growth. The Orlando, Fl.-based company was supported by its senior secured lender, PDL BioParhma Inc. In December 2015, healthcare and social commerce company Alphaeon bought the laser cataract treatment company for $59 million. Lensar said it anticipates that the company will file a plan to reduce its debt and convert a portion of PDL’s outstanding debt into equity. In the meantime, Lensar will continue to pay all employee wages and provide benefits, as well as pay all current operating expenses. “Given the growing aging population globally, with more than 22 million cataracts treated annually, I am very optimistic about th...



Staar Surgical wins Health Canada nod for Visian Toric ICL

Thu, 22 Sep 2016 21:28:44 +0100

Staar Surgical (NSDQ:STAA) said today it won approval from Health Canada’s Medical Devices Bureau for its Evo Visian Toric ICL intraocular lenses. The Evo Visian Toric ICL is designed to be implanted inside the eye between the iris and the natural lens indefinitely to correct vision, Monrovia, Calif.-based Staar Surgical said. “We are very pleased with Health Canada’s approval that allows us to offer the EVO Toric ICL for myopia and astigmatism, with a broad spherical power range of -3.0 to -18.0 diopters and cylinder power range of 1.0 to 6.0 diopters, to our surgeons and their patients in Canada. This represents an important new option for eligible patients between 21 and 45 years old living with nearsightedness and astigmatism treated in a single procedure. This approval r...



Staar Surgical inks 44-hospital distribution deal in India

Fri, 16 Sep 2016 23:10:07 +0100

Staar Surgical (NSDQ:STAA) said yesterday it inked a distribution agreement with India-based EyeQ Vision Private to distribute Staar Evo Visian ICL intraocular lenses as a treatment for refractive vision treatment. The deal includes supplying the lenses to 44 hospitals in north and west India, with plans to increase the number to 70 hospitals, including south and west India, within the next 2 years. “With expansion plans to grow from our 44 hospitals in North and West India to over 70 hospitals including South and West India within the next two years, we made the decision to partner with STAAR Surgical to offer the EVO line of implantable collamer lenses as a premium solution for our patients with mid-to high myopia, hyperopia and astigmatism. We also plan to broaden our surgical o...



'Internal astigmatism' doesn't compensate for changes in the eye over time

Mon, 29 Aug 2016 04:00:00 +0100

(Wolters Kluwer Health) For people with nearsightedness (myopia), the lens doesn't compensate for growth or other changes in the structure of the eye, according to a long-term follow-up study in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)



A'Symfony' of Hope for Cataract Patients A'Symfony' of Hope for Cataract Patients

Fri, 12 Aug 2016 17:09:15 +0100

From distance and near vision to astigmatism and chromatic aberration, the new Symfony intraocular lens seems to correct it all.Wills Eye Hospital (Source: Medscape Pharmacist Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




MassDevice.com +5 | The top 5 medtech stories for July 18, 2016

Mon, 18 Jul 2016 19:00:41 +0100

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. T2 Biosystems, Bayer ink blood disorder deal T2 Biosystems said today that it inked a deal with Bayer for research on blood coagulation disorders. The deal calls for T2 to provide its T2MR magnetic resonance-based diagnostic device to Bayer for a research program for drug and biomarker discovery in hemostasis. Read more 4. Medtronic wins FDA nod for 2-level cervical fusion with Prestige ...



FDA approves Abbott’s Tecnis Symfony lens for cataracts

Mon, 18 Jul 2016 09:55:00 +0100

The FDA last week granted pre-market approval to the Tecnis Symfony intraocular lens made by Abbott Medical Optics (NYSE:ABT) for treating patients with cataracts. The device is the 1st intra-ocular lens to provide extended depth of focus for better vision at near, intermediate and far distances, the federal safety watchdog said. Abbott said the FDA also approved a version for patients with astigmatism called the Tecnis Symfony Toric intraocular lens. “Abbott is focused on improving people’s vision and their lives by helping them stay healthy and active. Symfony offers patients, including those with astigmatism, an option for crisp, clear vision at all distances,” Thomas Frinzi, senior vice president of Abbott’s vision business, said in prepared remarks. “Thi...



FDA Approves the Tecnis Symfony® Intraocular Lenses, the First and Only Extended Depth of Focus Lenses for People with Cataracts

Fri, 15 Jul 2016 16:49:00 +0100

- Approval includes Toric version of Symfony IOL for people with astigmatism (Source: Abbott.com)



FDA Approves the Tecnis Symfony ® Intraocular Lenses, the First and Only Extended Depth of Focus Lenses for People with Cataracts

Fri, 15 Jul 2016 16:49:00 +0100

- Approval includes Toric version of Symfony IOL for people with astigmatism (Source: Abbott.com)



Astigmatism

Tue, 05 Jul 2016 07:00:00 +0100

(Source: eMedicineHealth.com)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




FDA releases May 2016 510(k) clearances

Wed, 08 Jun 2016 15:54:20 +0100

510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 TOTAL 510(k)s THIS PERIOD 213 TOTAL WITH SUMMARIES 205 TOTAL WITH STATEMENTS 8 May 2016 510(k) Clearances SHARE TWEET LINKEDIN PIN IT EMAIL PRINT 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 DEVICE: O-PEP PARI RESPIRATORY EQUIPMENT, INC. 510(k) NO: K150044(Traditional) ATTN: Michael Judge PHONE NO : 1 804 2537274 2412 PARI Way SE DECISION MADE: 27-MAY-16 Midlothian VA 23112 510(k) SUMMARY AVAILABLE FROM FDA DEVICE: ERBE ESU Model VIO dV with Accessories ERBE ELEKTROMEDIZIN GMBH 510(k) NO: K150364(Traditional) ATTN: Axel Retzlaff PHONE NO : 49 7071 7075534...



MassDevice.com +5 | The top 5 medtech stories for May 17, 2016

Tue, 17 May 2016 19:00:33 +0100

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Biostage unveils $5 million offering for organ regeneration tech Organ regeneration specialist Biostage, formerly know as Harvard Apparatus Regenerative Technology, announced that it will offer $5 million worth of common stock May 19 to fund its ongoing R&D efforts. BSTG shares closed down -3.5% at $1.65 apiece yesterday on the news. Read more 4. Staar Surgical wins Health Canada nod...



Staar Surgical wins Health Canada nod as shares hit 52-week low

Tue, 17 May 2016 11:14:08 +0100

Implantable contact lens maker Staar Surgical (NSDQ:STAA) said it earned Health Canada approval to sell its EVO Visian ICL in the country. The device to correct myopia and astigmatism is permanently implanted between the iris and the eye’s natural lens. Staar sells 3 implantable lenses under its Visian franchise, but none are available in the U.S., according to the company’s website. “We are very pleased with Health Canada’s approval that allows us to offer the EVO ICL for myopia, with a broad power range of -3.0 to -18.0 diopters, to our surgeons and their patients in Canada. This represents an important new treatment option for eligible patients between 21 and 45 years old living with nearsightedness. This approval reinforces our deep commitment to patients seek...



FDA releases February 2016 510(k) clearances

Tue, 05 Apr 2016 16:36:07 +0100

February 2016 510(k) Clearances 510(k) summaries or 510(k) statements for final decisions rendered during the period February 2016. TOTAL 510(k)s THIS PERIOD 224 TOTAL WITH SUMMARIES 213 TOTAL WITH STATEMENTS 11 February 2016 510(k) Clearances 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD February 2016 DEVICE: ANI Monitor MDOLORIS MEDICAL SYSTEMS SAS 510(k) NO: K142969(Traditional) ATTN: MATHILDE COLLET PHONE NO : 011 333 62092081 6, RUE DU PR LAGUESSE SE DECISION MADE: 23-FEB-16 LILLE FR 59037 510(k) SUMMARY AVAILABLE FROM FDA DEVICE: DBSWIN and VistaEasy Imaging Software Durr Dental AG 510(k) NO: K143290(Traditional) ATTN: Oliver Lange PHONE NO : 49 07142 7050 Hopfigheimer Strasse 17 SE DECISION MADE: 18-FEB-16 Bietigheim-Bissingen DE D-74321 510(k)...



Medtech approvals: FDA releases December 2015 PMAs

Tue, 02 Feb 2016 20:09:26 +0100

The Food & Drug Administration today released a list of pre-market approvals granted in December 2015: Summary of PMA Originals & Supplements Approved Originals: 2 Supplements: 81 Summary of PMA Originals Under Review Total Under Review: 58 Total Active: 32 Total On Hold: 26 Summary of PMA Supplements Under Review Total Under Review: 599 Total Active: 423 Total On Hold: 176 Summary of All PMA Submissions Originals: 3 Supplements: 92 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 81 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 163.1 FDA Time: 140.4 Days MFR Time: 22.7 Days PMA Original Approvals APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION / IN...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Medtech approvals: FDA releases October 2015 PMAs

Fri, 04 Dec 2015 18:10:18 +0100

The FDA today released its list of the pre-market approvals it granted for medical devices in October 2015: Summary of PMA Originals & Supplements Approved Originals: 9 Supplements: 133 Summary of PMA Originals Under Review Total Under Review: 58 Total Active: 32 Total On Hold: 26 Summary of PMA Supplements Under Review Total Under Review: 597 Total Active: 433 Total On Hold: 164 Summary of All PMA Submissions Originals: 7 Supplements: 74 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 133 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 161.5 FDA Time: 97.9 Days MFR Time: 63.6 Days PMA Original Approvals APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION /...



Health Tip: Managing Astigmatism

Tue, 27 Oct 2015 07:00:00 +0100

Title: Health Tip: Managing AstigmatismCategory: Health NewsCreated: 10/27/2015 12:00:00 AMLast Editorial Review: 10/27/2015 12:00:00 AM (Source: MedicineNet Eyesight General)



Medtech approvals: FDA releases May 2015 PMAs

Thu, 06 Aug 2015 16:28:03 +0100

The FDA today released its list of the pre-market approvals it granted for medical devices in May 2015: Summary of PMA Originals & Supplements Approved Originals: 5 Supplements: 51 Summary of PMA Originals Under Review Total Under Review: 55 Total Active: 26 Total On Hold: 29 Summary of PMA Supplements Under Review Total Under Review: 547 Total Active: 379 Total On Hold: 168 Summary of All PMA Submissions Originals: 1 Supplements: 62 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 51 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 109.5 FDA Time: 86.4 Days MFR Time: 23.1 Days PMA Original Approvals APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION / INDIC...



Cataract Basics and Beyond: Why Treatments Are Now Better Than Ever

Wed, 10 Jun 2015 20:12:26 +0100

Kira Manusis, MD Assistant Professor of Ophthalmology Co-Director, Cataract, Cornea and Refractive Surgery New York Eye and Ear Infirmary of Mount Sinai __________________________ If you are fortunate to live long enough, you will probably develop a cataract, the leading cause of vision loss in the United States. According to the National Eye Institute, more than half of all Americans develop a cataract by age 80. As our nation's senior population expands, the number of people aged 40 or older with cataracts is expected to double from 24.4 million to about 50 million by 2050. Cataract Basics A cataract is a clouding of the eye's lens, the normally transparent structure that focuses light onto the back of the eye, allowing us to see. Rather than a disease, most cataracts develop as pa...



Consumer Information on: STAR S4 IR Excimer Laser System and iDesign Advanced WaveScan Studio System - P930016S044

Fri, 05 Jun 2015 04:00:00 +0100

The STAR S4 IR Excimer Laser System (Laser System) and iDesign Advanced WaveScan Studio System (iDesign System) reduces or eliminates nearsightedness (myopia) and/or astigmatism. (Source: Food and Drug Adminstration (FDA): CDRHNew)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Outcomes After Diffractive Multifocal Toric IOL ImplantationOutcomes After Diffractive Multifocal Toric IOL Implantation

Fri, 10 Apr 2015 08:59:45 +0100

An evaluation of this procedure finds good visual and refractive outcomes in patients with corneal astigmatism. The British Journal of Ophthalmology (Source: Medscape Today Headlines)



Toric Lens May Improve Astigmatism After Cataract RemovalToric Lens May Improve Astigmatism After Cataract Removal

Tue, 27 Jan 2015 04:54:27 +0100

The toric intraocular lens also proved rotationally stable, but not everyone has found the data to be convincing. Medscape Medical News (Source: Medscape Medical News Headlines)



Pioneering plastic lens combats poor vision and cataracts

Mon, 22 Dec 2014 09:48:59 +0100

The lenses, offered at London’s Claremont Clinic for around £3,900 each, promise to restore vision to those plagued by failing eyesight as well as cataracts or astigmatism. (Source: the Mail online | Health)



Revolutionary lens restores complete vision to ageing eyes

Mon, 22 Dec 2014 06:15:27 +0100

New implant improves vision for older people struggling with cataracts, astigmatism, or long and short-sightedness. (Source: Telegraph Health)



FDA Advisory Panel Views Intraocular Lens Favorably FDA Advisory Panel Views Intraocular Lens Favorably

Mon, 17 Nov 2014 21:31:32 +0100

The FDA Ophthalmic Device Panel has voted nearly unanimously in favor of Alcon's combination product that corrects both presbyopia and astigmatism. Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




FDA Panel Recommends Intraocular Lens for AstigmatismFDA Panel Recommends Intraocular Lens for Astigmatism

Mon, 17 Mar 2014 22:20:57 +0100

An FDA panel has recommended approval for Staar's Visian toric lens for treatment of astigmatism, with reservations. Medscape Medical News (Source: Medscape Today Headlines)



UPDATE: Staar Surgical jumps on FDA panel nod

Mon, 17 Mar 2014 15:01:17 +0100

An FDA panel votes to recommend approval of Staar Surgical's Visian Toric implantable collamer lens for treating myopic astigmatism, sending shares up today on Wall Street. An FDA advisory panel voted last week to recommend approval for Staar Surgical's (NSDQ:STAA) Visian Toric implantable collamer lens for myopic astigmatism, sending STAA shares up nearly 17% today. Food & Drug Administration (FDA), STAAR Surgical Co.News Well, Optical/Ophthalmic, Regulatory/Complianceread more (Source: Mass Device)



FDA panel recommends approval of Staar Surgical's novel eye implant

Fri, 14 Mar 2014 22:39:25 +0100

The FDA's ophthalmic devices advisory panel votes that Staar Surgical's breakthrough implantable lens is safe and effective and that its benefits outweigh its risks. An FDA panel voted today to recommend approval for Staar Surgical's (NSDQ:STAA) novel Visian Toric implantable collamer lens for treatment of myopic astigmatism in adults aged 21-45. Food & Drug Administration (FDA), STAAR Surgical Co.News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Optical/Ophthalmic, Pre-Market Approval (PMA)read more (Source: Mass Device)



Better Solutions for AstigmatismBetter Solutions for Astigmatism

Wed, 19 Feb 2014 01:21:53 +0100

Dr. Roger Steinert reports how astigmatism correction during cataract surgery is improving, a fraction of a diopter at a time. Medscape Ophthalmology (Source: Medscape Ophthalmology Headlines)



Varioptic Launches A Variable Focus, Tilt And Astigmatism Liquid Lens For Ophthalmology Applications

Mon, 03 Feb 2014 00:26:12 +0100

Varioptic, a Business Unit of Parrot SA, will announce its new Visayan series of products dedicated to the ophthalmology market at the Photonics West trade show, which will be held from February 4 to 6, 2014 in San Francisco, California. (Source: Medical Design Online News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Visual performance and ocular abnormalities in deaf children and young adults: A literature review - Hollingsworth R, Ludlow AK, Wilkins A, Calver R, Allen PM.

Wed, 25 Dec 2013 00:15:36 +0100

Visual defects are common in deaf individuals. Refractive error and ocular motor abnormalities are frequently reported, with hyperopia, myopia, astigmatism and anomalies of binocular vision, all showing a greater prevalence in deaf individuals compared wit... (Source: SafetyLit: All (Unduplicated))



Consumer Information on: Nidek EC-5000 Excimer Laser System - P970053/S011

Wed, 30 Oct 2013 04:00:00 +0100

The Nidek EC-5000 Excimer Laser System is an ophthalmic laser system for refractive surgery of the cornea designed to correct the vision of patients with refractive errors (nearsightedness and astigmatism) by laser assisted in-situ keratomileusis (LASIK). (Source: Food and Drug Adminstration (FDA): CDRHNew)



Astigmatism

Tue, 25 Jun 2013 07:00:00 +0100

Title: AstigmatismCategory: Diseases and ConditionsCreated: 1/31/2005 5:59:00 AMLast Editorial Review: 6/25/2013 12:00:00 AM (Source: MedicineNet Eyesight General)



Consumer Information on: Trulign Toric Posterior Chamber Intraocular Lens and Trulign Toric IOL Calculator - P030002S027

Tue, 18 Jun 2013 04:00:00 +0100

The Trulign Toric Posterior Chamber Intraocular Lens (IOL) is an artificial lens. It is used restore vision after removal of the eye?s natural lens during cataract surgery. In addition, it corrects blurry vision due to corneal astigmatism. (Source: Food and Drug Adminstration (FDA): CDRHNew)



FDA Approves Trulign Intraocular LensFDA Approves Trulign Intraocular Lens

Wed, 22 May 2013 21:44:57 +0100

Intraocular lens provides correction for astigmatism while delivering a broad range of improved vision for patients undergoing cataract surgery, the company says. FDA Approvals (Source: Medscape Today Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Astigmatism Correction With Toric Intraocular LensesAstigmatism Correction With Toric Intraocular Lenses

Fri, 10 May 2013 16:00:00 +0100

How do patients with astigmatism fare after toric IOL implantation? Are both quality of life and visual acuity improved? The British Journal of Ophthalmology (Source: Medscape Ophthalmology Headlines)



Consumer Information on: TECNIS Toric 1-Piece Intraocular Lens (IOL) Models: ZCT150, ZCT225, ZCT300, ZCT400 - - P980040S039

Wed, 24 Apr 2013 04:00:00 +0100

The TECNIS Toric 1-Piece Intraocular Lens (IOL) is an artificial lens used to correct corneal astigmatism (a football-shaped cornea or an irregularly shaped cornea) and restore distance vision after removal of the natural lens of the eye during cataract.. (Source: Food and Drug Adminstration (FDA): CDRHNew)



An International Survey of Toric Contact Lens PrescribingAn International Survey of Toric Contact Lens Prescribing

Fri, 19 Apr 2013 16:00:00 +0100

Are clinicians properly prescribing toric soft contact lenses for patients with astigmatism? Eye & Contact Lens (Source: Medscape Today Headlines)



FDA Approves Tecnis Toric Intraocular LensFDA Approves Tecnis Toric Intraocular Lens

Thu, 18 Apr 2013 22:00:39 +0100

New lenses target patients with cataract who have astigmatism. FDA Approvals (Source: Medscape Today Headlines)



Abbott Announces FDA Approval and U.S. Launch of the TECNIS(R) Toric Intraocular Lens for Cataract Patients

Thu, 18 Apr 2013 15:22:35 +0100

ABBOTT PARK, Ill., April 18, 2013 -- (Healthcare Sales & Marketing Network) -- Abbott (ABT) today announced that the TECNIS® Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) approval and is launching in the Uni... Devices, Ophthalmology, FDA, Product LaunchAbbott, intraocular lens, TECNIS Toric, astigmatism (Source: HSMN NewsFeed)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Podcast: Terry Kim, MD, on Eye Health Screenings

Fri, 22 Mar 2013 18:09:45 +0100

In this podcast, Terry Kim, MD, the Duke Men's Basketball team physician, discusses the vision and eye health screenings he performs for the team and how it helps their performance on the court. Listen to the Podcast (Download audio) Podcast Transcript: Radio Announcer:  We’ve got a lot to cover on today’s show. We’re going to begin with a special guest who’s joining us up here in our “Crow’s Nest” position overlooking Coach K Court.  He’s Dr. Terry Kim who’s a professor of ophthalmology at the Duke Eye Center here on campus. Dr. Kim, I know you’re the team eye doctor for the Duke Men’s Basketball program so we thought we’d get you tell us a little about some of the things you do for the team as far as how you screen them and how it helps their performance in...



Posterior Corneal Astigmatism: Not to Be Ignored!Posterior Corneal Astigmatism: Not to Be Ignored!

Tue, 19 Feb 2013 19:18:29 +0100

Dr. William Culbertson explains why ignoring posterior corneal astigmatism may yield incorrect estimation of total corneal astigmatism and less-than-satisfactory surgical results. Medscape Ophthalmology (Source: Medscape Today Headlines)



Modern Management of AstigmatismModern Management of Astigmatism

Tue, 29 Jan 2013 20:04:01 +0100

Are there any new and improved methods for managing astigmatism? Read this study to find out about the latest treatment strategies. International Ophthalmology Clinics (Source: Medscape Ophthalmology Headlines)